Table 1.
Patients characteristics
| Characteristic | No. of patients (%) | ||
|---|---|---|---|
| No. of patients | 101 | ||
| Sex | |||
| Male | 83 | (82) | |
| Female | 18 | (18) | |
| Age, years | |||
| Median (Range) | 65 | (32–82) | |
| Pathology | |||
| Clear cell | 86 | (85) | |
| Papillary | 6 | (6) | |
| Clear cell/Sarcomatoid | 4 | (4) | |
| Sarcomatoid | 2 | (2) | |
| Hemodialyssis | 2 | (2) | |
| Unclassified | 1 | (1) | |
| Prior nephrectomy | |||
| Yes | 77 | (76) | |
| No | 24 | (24) | |
| Disease status | |||
| Recurrent | 61 | (60) | |
| Metastatic | 58 | (57) | |
| Regional | 3 | (3) | |
| Stage IV | 40 | (40) | |
| Locoregional | 4 | (4) | |
| Metastatic | 36 | (36) | |
| Prior systematic Therapy | |||
| Yes | 17 | (17) | |
| IFN-α | 9 | ||
| IFN-α/sorafenib | 2 | ||
| Sorafenib | 2 | ||
| Sunitinib | 1 | ||
| S-1 | 1 | ||
| IFN-α/UFT | 1 | ||
| Sorafenib/Temsirolimus | 1 | ||
| No | 84 | 83 | |
Abbreviation: IFN-α interferon-α